Silva Ninan

Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom.

Consort Medical Ltd. is a holding company, which engages in pharmaceutical industry related activities. It focuses on the design, development, manufacture, and sale of medical drug and delivery devices. The company was founded on March 22, 1946 and is headquartered in Kings Lynn, the United Kingdom.